Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.
In 2023, the sales revenue of Chong Kun Dang amounted to around 1.7 trillion South Korean won. This represents an increase compared to the previous year. It was also the highest sales figure recorded since 2015.
Sales revenue of Chong Kun Dang from 2015 to 2023 (in billion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Pharmaceutical industry in South Korea
Overview
7
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
- Premium Statistic Pharmaceuticals market size South Korea 2012-2022
- Basic Statistic Pharmaceutical spending as share of GDP South Korea 2000-2022
- Basic Statistic Pharmaceutical spending per capita in South Korea 2000-2022
- Premium Statistic Pharmaceutical medications sales South Korea 2019-2022
- Premium Statistic Pharmaceutical medications taken in South Korea 2019-2022
- Premium Statistic Number of pharmaceutical manufacturers South Korea 2012-2022
Production and distribution
6
- Basic Statistic Pharmaceutical production value South Korea 2012-2022
- Premium Statistic OTC drug products production value South Korea 2012-2022
- Premium Statistic Prescription drug products production value South Korea 2012-2022
- Premium Statistic Leading pharmaceutical products South Korea 2022, by production value
- Premium Statistic Number of pharmaceutical distributors South Korea 2012-2022
- Premium Statistic Number of pharmaceutical distributors South Korea 2022, by type
International trade
6
- Premium Statistic Pharmaceutical export value from South Korea 2012-2022
- Premium Statistic Leading countries for pharmaceutical exports South Korea 2022, by export value
- Premium Statistic Biopharmaceuticals export value from South Korea 2012-2022
- Premium Statistic Pharmaceutical import value in South Korea 2012-2022
- Premium Statistic Leading countries for pharmaceutical imports South Korea 2022, by import value
- Premium Statistic Biopharmaceutical import value in South Korea 2012-2022
Key players
6
- Premium Statistic Leading pharmaceutical businesses South Korea 2023, by revenue
- Premium Statistic Sales revenue Yuhan 2015-2023
- Premium Statistic Revenue of Chong Kun Dang 2015-2023
- Premium Statistic Sales revenue of GC Pharma 2015-2023
- Premium Statistic Sales revenue Kwang Dong Pharmaceutical 2013-2023
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2023
Pharmaceutical drug consumption
5
- Premium Statistic Pharmaceutical level 1 drugs consumed South Korea 2022, compared to OECD
- Premium Statistic Value of pharmaceutical level 1 drugs consumed South Korea 2022, compared to OECD
- Premium Statistic Major pharmaceutical level 1 drugs consumed South Korea 2022
- Premium Statistic Major pharmaceutical level 2 drugs consumed South Korea 2022
- Premium Statistic Major pharmaceutical level 3 drugs consumed South Korea 2022
Further related statistics
19
- Celltrion R&D investment South Korea 2013-2017
- Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Biosimilar market size Japan 2018-2030
- Biopharmaceutical market size forecast Japan 2011-2020
- Share of Novo Nordisk in insulin market in Greater China 2019, by segment
- Biopharmaceuticals market value in Latin America 2022-2027
- Average peak sales forecast per new biopharmaceutical asset 2013-2022
- Employment in pharma industry in Colombia 2014-2020
- Net income Yuhan 2015-2022
- Sales revenue from non-prescription drugs Yuhan 2016-2022
- VECOL S.A.: net sales breakdown 2016-2018, by segment
- Pharmaceuticals production value in Colombia 2014-2020
- VECOL S.A.: net income 2016-2018
- Operating income Yuhan 2015-2022
- Belgium: number of manufacturers of basic pharmaceutical products 2009-2020
- Net profit of Daewoong Pharma 2015-2022
- Turkey: number of manufacturers of basic pharmaceutical products 2009-2014
- Norway: number of manufacturers of basic pharmaceutical products 2012-2022
Further Content: You might find this interesting as well
Statistics
- Celltrion R&D investment South Korea 2013-2017
- Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Biosimilar market size Japan 2018-2030
- Biopharmaceutical market size forecast Japan 2011-2020
- Share of Novo Nordisk in insulin market in Greater China 2019, by segment
- Biopharmaceuticals market value in Latin America 2022-2027
- Average peak sales forecast per new biopharmaceutical asset 2013-2022
- Employment in pharma industry in Colombia 2014-2020
- Net income Yuhan 2015-2022
- Sales revenue from non-prescription drugs Yuhan 2016-2022
- VECOL S.A.: net sales breakdown 2016-2018, by segment
- Pharmaceuticals production value in Colombia 2014-2020
- VECOL S.A.: net income 2016-2018
- Operating income Yuhan 2015-2022
- Belgium: number of manufacturers of basic pharmaceutical products 2009-2020
- Net profit of Daewoong Pharma 2015-2022
- Turkey: number of manufacturers of basic pharmaceutical products 2009-2014
- Norway: number of manufacturers of basic pharmaceutical products 2012-2022
DART. (March 20, 2024). Sales revenue of Chong Kun Dang from 2015 to 2023 (in billion South Korean won) [Graph]. In Statista. Retrieved May 16, 2024, from https://www.statista.com/statistics/1164989/chong-kun-dang-sales-revenue/
DART. "Sales revenue of Chong Kun Dang from 2015 to 2023 (in billion South Korean won)." Chart. March 20, 2024. Statista. Accessed May 16, 2024. https://www.statista.com/statistics/1164989/chong-kun-dang-sales-revenue/
DART. (2024). Sales revenue of Chong Kun Dang from 2015 to 2023 (in billion South Korean won). Statista. Statista Inc.. Accessed: May 16, 2024. https://www.statista.com/statistics/1164989/chong-kun-dang-sales-revenue/
DART. "Sales Revenue of Chong Kun Dang from 2015 to 2023 (in Billion South Korean Won)." Statista, Statista Inc., 20 Mar 2024, https://www.statista.com/statistics/1164989/chong-kun-dang-sales-revenue/
DART, Sales revenue of Chong Kun Dang from 2015 to 2023 (in billion South Korean won) Statista, https://www.statista.com/statistics/1164989/chong-kun-dang-sales-revenue/ (last visited May 16, 2024)
Sales revenue of Chong Kun Dang from 2015 to 2023 (in billion South Korean won) [Graph], DART, March 20, 2024. [Online]. Available: https://www.statista.com/statistics/1164989/chong-kun-dang-sales-revenue/